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       General Introduction
 4 
  Malnutrition has been defined as a pathologic state resulting from a relative or absolute 
deficiency or excess of one or more essential nutrients. The causes of malnutrition include 
malabsorption, inability to take in nutrients, and hypermetabolism (Young, 1988). The 
prevalence of malnutrition among hospitalized patients has been well documented in human 
medicine, especially for surgical patients and critically ill patients (Bistrian et al., 1975; 
Mullen et al., 1980). Malnutrition causes loss of lean body mass (LBM), mostly muscle 
mass, and results in impaired immune response and wound healing response to trauma 
(Young, 1988), increased infectious morbidity and even death (i.e., nitrogen death) (Steffee, 
1980) in human. Appropriate nutritional treatment has long been considered important to 
preserve or normalize lean body mass, and essential for the recovery of critically ill human 
patients (Roubenoff and Kehayias, 1991). Furthermore, it has been suggested that early 
recognition of malnutrition and aggressive treatment could reduce the duration of 
hospitalization and cost (Robinson et al., 1987). 
   Malnutrition, negative nitrogen balance or net protein loss during hospitalization has 
been also reported in critically ill dogs and cats (Chan, 2004; Michel, 1993; Michel et al., 
2004), Although there is convincing evidence of the deleterious effects of malnutrition in 
people, the optimal nutritional strategies for critically ill animals remain controversial and 
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largely unknown. Therefore, recommendations for nutritional support of critically ill 
animals are generally based on adequate clinical judgment and the limited information 
available (Chan, 2004). 
   Nutritional assessment is the most important first step for planning any nutritional 
treatment (Oka et al., 2006). Good nutritional assessment consists of screening to identify 
patients at risk, followed by an overall evaluation of the nutritional condition and nutrition 
planning if necessary (Armstrong and Lippert, 1988; Chan, 2004). The nutritional status of 
diseased dogs is currently estimated on the basis of body weight (Armstrong and Lippert, 
1988; Michel, 1993; Michel et al., 2004), body condition score (BCS) (Michel, 1993; 
Michel et al., 2004), and several serum biochemical values (Michel, 1993). However, it is a 
static factor and does not reflect short-term changes. There is few detailed research on the 
nutritional assessment, especially for critically ill animal patients. In human patients, rapid 
turnover proteins (RTPs) have recently been used as serum nutritional indicator to reflect the 
short-term change of nutritional conditions. 
   RTPs such as transferrin (Tf) and retinol-binding protein (RBP) are metabolized with 
short half-lives and have relatively small body pool (Fuhrman et al., 2004). These 
characteristics of RTPs are advantageous for the estimation of short-term nutritional change 
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and have been used as dynamic nutritional assessment proteins in human medicine 
(Ingenbleek et al., 1975; Winkler et al., 1989a; Winkler et al., 1989b). 
   In chapter 1, I evaluated the serial change of plasma Tf and RBP concentrations under 
experimentally caloric restriction in dogs. Furthermore, plasma Tf concentrations were 
measured in dogs diagnosed as chronic gastrointestinal disease with or without anorexia to 
examine its clinical value as a nutritional marker. In chapter 2, I evaluated the relationships 
between plasma Tf concentration and the nutritional condition and prognosis in 
malnourished diseased dogs receiving nutritional treatment, and compared with other 
conventional parameters.  
   Nutrition treatment/support in veterinary medicine includes oral-assisted feeding, 
enteral-assisted (tube) feeding, and parenteral nutrition through a catheter that is inserted 
directly into the veins. Oral- or enteral-assisted feedings are generally recommended first 
for its beneficial effect on the integrity of gut mucosa (Mohr et al., 2003), which is critical 
to digest and absorb nutrients. Absorption ability is reported to become remarkably 
diminished under various situation as intestinal inflammation caused by Crohn’s disease in 
human patient (D'Agostino et al., 1991b) and experimentally induced injury by (Hughes 
and Dowling, 1980) methotrexate in rats (Naruhashi et al., 2000). Furthermore, prolonged 
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parenteral nutritional is also reported to diminish absorption ability because of atrophy in 
intestinal mucosa in rats (Hughes and Dowling, 1980; Illig et al., 1992). Atrophy of gut 
mucosa and appended organs is reported in patients with protein malnutrition as well 
(Hartman et al., 2009). 
   For nutritional assessment and for adequate planning of nutritional supports of 
malnourished patients, intestinal integrity should be evaluated as well as the static and 
dynamic nutritional condition. At present, the intestinal integrity is estimated based on 
histopathological evaluation using the endoscopic biopsy sample. However, it is not suitable 
for repetitive evaluation, especially in critically ill dogs due to the need of anesthesia. 
Further, it is difficult to estimate the function of the whole intestinal tract from 
histopathological findings using small numbers of biopsy samples.  
   Diamine oxidase (DAO) is an enzyme performing oxidative diaminating of several 
polyamines, which inhibit cell proliferation. The activity of DAO is reported to be related to 
the intestinal mucosa integrity by controlling cell proliferation of villus in human and rats 
(Wolvekamp and de Bruin, 1994). There is a linear relationship between DAO activities of 
intestinal mucosa and plasma in patients with intestinal disease (Rokkas et al., 1990). It has 
been also reported that plasma DAO activity was greatly influenced by nutritional 
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management and administration of dietary fiber and/or cyclophosphamide (Tanaka et al., 
2003). In chapter 3, I measured serum DAO activity in dogs with chronic enteritis and 
discuss its possibility as a clinical marker to assess intestinal mucosa integrity. 
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Chapter 1 
 
Usefulness of plasma transferrin concentration as a    
  dynamic nutritional assessment marker in dogs
 10 
Abstract 
 
Rapid turnover proteins (RTPs) such as transferrin (Tf) and retinol-binding protein 
(RBP) has been used as a dynamic nutritional assessment marker in human medicine. The 
purpose of the present study is to evaluate the clinical usefulness of plasma Tf and RBP 
concentration as a nutritional assessment marker in dogs. By restricting the total calorie 
intake to <50% resting energy requirement (RER) in healthy dogs for 2 weeks, plasma Tf 
concentrations were significantly decreased, which was gradually recovered after bringing 
the caloric intake back to adequate level. In contrast, plasma RBP and albumin 
concentrations showed no significant change throughout the study. Next, plasma Tf 
concentrations were measured in dogs with chronic gastrointestinal diseases. The dogs were 
divided to 2 groups; <50% RER group, calorie intake <50% RER for more than 1 week; 
≥50% RER group, caloric intake ≥50% RER for more than 1 week. Plasma Tf cocentrations 
were significantly low in severely anorexic dogs (<50% RER group) compared to 
non-severely anorexic dogs (≥50% RER group) (P<0.05) while plasma albumin 
concentrations were not different. Taken together, measurement of plasma Tf concentration 
would be useful to evaluate short-term nutritional status in dogs.
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Introduction 
 
 
Malnutrition is caused by various factors such as critical illness or insufficient food 
intake, and is reported to increase the morbidity and the mortality in human patients 
(Heyland, 2000; Kuvshinoff et al., 1993; Mullen et al., 1980; Smale et al., 1981). Therefore, 
nutritional support/treatment to prevent malnutrition is now considered essential for the 
recovery of human patients (Roubenoff and Kehayias, 1991). Adequate nutritional 
treatments have been reported to improve the postoperative recovery and decrease the 
mortality in hospitalized patients (Heyland, 2000). Recognition that malnutrition may 
similarly affect veterinary patients emphasizes the need to properly address the nutritional 
requirements of hospitalized dogs and cats. However, little information is available about the 
nutritional requirement of critically ill small animals.  
Nutritional assessment is an important first step to determine the patients in need of 
nutritional treatment and to select the adequate treatment (Oka et al., 2006). At present, 
nutritional status of diseased dogs are estimated based on body weight change (Armstrong 
and Lippert, 1988; Michel, 1993; Michel et al., 2004), body condition score (BCS) (Michel, 
1993; Michel et al., 2004), and several serum biochemical values such as plasma albumin 
concentration (Michel, 1993). These parameters are called static nutritional assessment 
markers that reflect average nutritional status of the past several weeks to months. Body 
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weight change is the most reliable factor assessing the nutritional condition, however, it does 
not change in a short duration. Additionally, fluid accumulation in the third space has a 
direct effect on body weight making the assessment difficult. Although BCS is a convenient 
and non-invasive method to estimate nutritional status of dogs, it is a subjective marker and 
also affected by the variability of body size and shape among different breeds. Plasma 
albumin concentration is commonly used biochemical value to assess nutritional status in 
dogs (Michel, 1993). Because the half-life of albumin in dog is 8.2 days (Dixon et al., 1953), 
it is expected to be a short-to medium term nutritional assessment marker. However, plasma 
albumin concentration is readily influenced by fluid accumulation, hepatic function, and 
protein loss from small intestine or kidney. In addition, plasma albumin concentration rarely 
decline unless the malnutrition is in the advanced stage, perhaps in part because of the large 
capacity of the liver to synthesize albumin (Shetty et al., 1979). As serum nutritional 
indicator for human patients, rapid turnover proteins (RTPs) such as transferrin (Tf) and 
retinol-binding protein (RBP) have recently been used as dynamic nutritional markers to 
reflect the short-term change (Raguso et al., 2003).  
Tf and RBP play important roles on iron (Hassanein el et al., 1998; Kalantar-Zadeh et al., 
1998; Reddy et al., 1970) or vitamin A transport (Ingenbleek et al., 1975), respectively. Both 
Tf and RBP are synthesized by hepatocytes, released into the circulation, and metabolized 
with short half-lives (Tf: 8.8 days; RBP: 12 hours in human) (Winkler et al., 1989a). 
Because of the relatively small body pool and a rapid turn-over rate (Raguso et al., 2003), 
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serum RTP such as Tf or RBP concentrations had been expected to decline rapidly along 
with deterioration of the nutritional condition than albumin. Indeed, serial measurement of 
RTPs is reported to be a useful marker to monitor nutritional status (Inoue et al., 1995; 
Winkler et al., 1989b) in human patients. In the field of veterinary medicine, however, the 
clinical usefulness of plasma RTP concentrations as dynamic nutritional assessment markers 
have not been studied so far.  
In this study, I evaluated the serial change of plasma Tf and RBP concentrations under 
experimentally caloric restriction in dogs. Furthermore, plasma Tf concentrations were 
measured in dogs diagnosed as chronic gastrointestinal disease with or without severe 
anorexia to examine its clinical value as a nutritional marker. 
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Materials and Methods 
 
Dogs 
Thirteen healthy laboratory beagles kept in the animal facility of the Veterinary Medical 
Center of the University of Tokyo were used as controls to determine the reference range of 
the plasma Tf and RBP concentrations in dogs.  
Plasma samples from 64 dogs referred to the Veterinary Medical Center of the University 
of Tokyo with chronic gastrointestinal diseases with persisted gastrointestinal symptoms for 
more than 3 weeks were also used. Dogs were divided into two groups according to the 
amount of daily food intake estimated by the interview with the owners: (1) ≥50%RER 
group: caloric intake higher than 50% RER for more than 1 week before the admission date, 
and (2) <50% RER group: caloric intake lower than 50% RER for more than 1 week. RER 
was calculated based on body weight as described in below. Dogs with plasma C-reactive 
protein (CRP) higher than 1 mg/dl, iron deficiency anemia, or liver cirrhosis, were excluded 
from the study due to the possible influence on the Tf concentration (Fleck, 1989; 
Kalantar-Zadeh et al., 1998). 
 
Experimental short-term calorie restriction  
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Short-term calorie restriction was performed on 5 healthy laboratory beagles as follows: 
(1) calorie increase period, 1.5 × daily energy requirement (DER) for 7 days, (2) calorie 
reduction period, 0.5 × resting energy requirement (RER) for 14 days, (3) calorie re-increase 
period, 1.5 × DER for 14 days. Plasma samples were collected on day 0, 3, 7, 10, 14, 17, 21, 
24, 28, 31 and 35 at early morning under fasting condition, and used for measurement of 
plasma Tf, RBP and albumin concentrations. Body weight and body condition score (BCS: 5 
point scale) were also monitored during the study. RER was calculated according to the 
following formula: RER = 30 x weight (kg) + 70, DER = RER × 1.6 (Mark, 2001). In the 
calorie restriction period, a commercial canine low-energy diet (Hill’s prescription Diet r/d 
Canine, Hill’s Pet nutrition, Topeka, KS) was fed to all dogs. In other periods, a maintenance 
diets (CXD-M, Dechra Veterinary Products, Shropshire, UK) was fed. This study was 
approved by the Animal Care Committee of the University of Tokyo. 
 
Measurement of plasma Tf, RBP and albumin concentrations 
Plasma Tf, RBP and albumin concentrations were measured using plasma collected at 
fasting condition. Plasma were immediately stored at -20 ℃ after preparation until 
measurement. Plasma Tf concentrations were determined by using a commercial kit (canine 
Tf ELISA kit: GenWay biotech, San Diego, CA) according to the manufactures’ protocol 
using 1:50000 diluted plasma samples. The measurement range was 6.25 - 400 ng/mL, the 
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inter-assay % CVs of within 20 were acceptable. Plasma RBP concentrations were 
determined by using a commercial kit (human RBP ELISA kit: Immundiagnostik, Bensheim, 
Germany) according to the manufactures’ protocol using 1:400 diluted plasma. The 
measurement range was 1.1 - 33μ/L and the inter-assay % CVs of within 10 were 
acceptable. The incubation time with the chromogen substrate was set as 10 minutes for 
both plasma Tf and RBP concentration measurements. Cross-reactivity between the rabbit 
anti-human RBP polyclonal antibody and canine plasma RBP was tested by Western blotting 
according to the previous report (data not shown) (Raila et al., 2000). Plasma albumin 
concentrations were measured using biochemical analyzer (Dry-chem 7000V: Fuji film CO. 
Tokyo, Japan). All samples were measured in duplicate.  
 
Statistical analysis  
All statistical analysis was performed using SAS software (SAS Institute, Cary, NC). The 
normality of the data was assessed using the Shapiro-Wilk test. Dunnett’s multiple 
comparison test and Tukey’s post hoc tests were used to compare the change of plasma Tf, 
RBP, and albumin concentrations. The difference of plasma Tf and albumin concentrations 
between 2 groups were analyzed by t test. A second degree polynomial curve that fits the 
serial data of Tf, RBP and albumin is determined, and a statistical significance value for the 
curve fit is determined by regression analysis using SAS GLM procedure. Receiver 
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operating characteristics curve (ROC curve) was used to find out the cut-off line of plasma 
Tf and ALB which distinguish between <50% RER groups and ≥50% RER groups. 
Statistical significance was defined as P<0.05.
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Results 
 
Determination of the plasma Tf and RBP reference range 
Plasma Tf and RBP concentrations of 13 healthy dogs were normally distributed 
according to the statistical analysis. The mean and SD (standard deviation) values were 240 
mg/dl and 29 mg/dl for plasma Tf concentration and 0.62 mg/dL and 0.13 mg/dL for plasma 
RBP concentration, respectively. From these results, the reference range of plasma Tf 
concentration was determined to be 180 - 300 mg/dL, and that of plasma RBP concentration 
was determined to be 0.36 - 0.88 mg/dL. 
 
Plasma Tf and albumin concentration in healthy dogs under short-term calorie restriction 
tests 
 In test 1, food intake was first increased for 7 days, and then decreased for 14 days 
followed by 14 days of re-increase period. Plasma Tf concentrations started to decrease after 
day 7, the beginning of the calorie reduction period. Mean plasma Tf concentration was 
significantly decreased on day 14 (280 mg/dL), day 17 (250 mg/dL) and day 21 (260 
mg/dL) compared to day 7 (350 mg/dL). Plasma Tf concentration increased after day 21 by 
re-increasing caloric intake, showing no significant difference compared to day 7 (Fig.1). 
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Although there was no significant difference in plasma Tf concentration at any time point 
when compared to day 21, the significant (P<0.0001) fit to a second degree polynomial 
curve was observed during the calorie re-increase period. Plasma Tf concentration under the 
lower limit of the reference range (<180mg/dL) was observed at none of the time point 
throughout the experiment. On the other hand, plasma RBP and albumin concentrations 
were kept within the normal reference range throughout the experiment (Fig. 1), and they 
were not significantly different at any time point when compared to day 7 at the beginning 
of caloric reduction period, or day 21 at the beginning of caloric re-increase period. 
Furthermore, there were no significant fit to second degree polynomial curves in RBP 
(P=0.1387) and in albumin (P=0.3868). Mean body weight (range; 11.2 to 12 kg) and mean 
BCS score (range; 3-4) were not significantly different at any time point when compared to 
day 7 at the beginning of caloric reduction period, or day 21 at the beginning of caloric 
re-increase period.  
 
Plasma Tf and albumin concentration in dogs with chronic gastrointestinal disease with or 
without anorexia 
Sixty-four dogs diagnosed as chronic gastrointestinal disease were divided to 2 groups 
(Table 1) according to the amounts of daily food intake: Food intake ≥50% RER (n=42) 
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without anorexia, and food intake <50% RER (n=22) with anorexia. Breeds included in the 
≥50% RER group were Miniature Dachshund (n=5), Chihuahua and Toy Poodle (n=4 each), 
Japanese Shiba Inu and Pug (n=3 each), Cairn Terrier, Shetland Sheepdog, Miniature 
Schnauzer, Papillon, Boston terrier and Mongrel (n=2 each), Pembroke Welsh Corgi, Jack 
Russell Terrier, Labrador Retriever, Hokkaido dog, Yorkshire Terrier, Maltese, Shih Tzu, 
Borzoi, Italian Greyhound, Miniature Pinscher, Whippet (n=1 each). In the <50% RER 
group, Miniature Dachshund (n=4), Yorkshire Terrier (n=3), Labrador Retriever (n=2), Jack 
Russell Terrier, Japanese Shiba Inu, Golden Retriever, Toy Manchester Terrier, Basenji, 
Beagle, Shetland Sheepdog, Shih Tzu, Chihuahua, Collie, Pug, West Highland White 
Terrier and Mongrel (n=1 each) were included. Diagnoses of the dogs in the ≥50% RER 
group include protein losing enteropathy (PLE) in 28 dogs, enteritis without PLE in 10 dogs 
and other enteropathy in 4 dogs. In <50% RER group, diagnoses include PLE in 15 dogs, 
enteritis without PLE in 4 dogs and other enteropathy in 3 dogs. Age and sex were not 
significantly different between the two groups: 21 females (12 intact) and 21 males (11 
intact) with median age of 7.08 years (range; 1.16-14.1) in the ≥50% RER group; 9 females 
(6 intact) and 13 males (9 intact) with median age of 8.70 years (range; 2.00-15.2) in the 
<50% RER group. The mean body weight was 5.65 kg (range; 1.5-24.8) and 5.45 kg (range; 
2-34), and the median BCS score was 3/5 (range; 1-4) and 2/5 (range; 1-3) in the ≥50% RER 
group and the <50% RER group, respectively.  
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The mean plasma Tf concentrations in the ≥50% RER group were 200 mg/dl (range; 
130-270 mg/dl), and 130 mg/dl (range; 60-200 mg/dl) in the <50% RER group. Plasma Tf 
concentrations in the <50% RER group were significantly lower compared to that in the 
≥50% RER group (P=0.01). Furthermore, 18 dogs (82%) in the <50% RER group and 21 
dogs in the ≥50% RER group (50%) showed plasma Tf concentrations lower than the 
normal limit (180 mg/dl) (Fig. 2A). When the cut-off line of Tf was set as the lower limit of 
the reference range (180 mg/dl), sensitivity and specificity to predict <50% RER dogs were 
about 57% and 82%, respectively. 
On the other hand, there was no significant difference in mean plasma albumin 
concentration between ≥50% RER group (mean; 2.6 g/dL, range; 1.8-3.4 g/dL) and < 
50%RER group (mean; 2.6 g/dL, range; 1.6-3.6 g/dL) (Fig. 2B). 
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Discussion 
 
In the present study, plasma Tf and RBP concentrations were measured in dogs and 
evaluated their clinical usefulness as nutritional markers. First, the reference range of the 
plasma Tf and RBP concentrations in dogs were determined as 180-300 mg/dL and 
0.36-0.88 mg/dL, respectively. The reference ranges of plasma Tf and RBP concentration in 
human were reported to be 160-360 mg/dL and 3-6 mg/dL, respectively (Winkler et al., 
1989b). The reference range of plasma Tf concentrations in dogs was similar to that in 
human, while the reference range of plasma RBP concentrations was lower than that in 
humans. Although the reason for the discrepancy is unknown, one possible explanation is 
that the sensitivity of the ELISA (e.g., lower affinity of monoclonal antibody) used in this 
study might affect the results of RBP concentration. Another possibility is the difference in 
vitamin A metabolism between dog and human described below. 
In experimental calorie restriction using clinically healthy dogs, significant reduction in 
plasma Tf concentration was observed during caloric reduction period. On the other hand, 
plasma RBP and albumin concentration was not significantly different at any time point of 
caloric reduction period. These results are consistent with the previous report in which 
plasma Tf but not albumin was decreased in human patients group with low-protein diet 
(Kopple et al., 1997). In the study of canine anorexic patients, plasma Tf concentration in 
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the <50% RER group was also significantly decreased compared to the ≥50% RER group 
while plasma albumin concentration was not different between both groups. From these 
results, plasma Tf concentration was suggested to be a promising nutritional assessment 
marker in dogs, reflecting the preceding 1-2 weeks calorie intake, which is more dynamic 
compared to plasma albumin concentration.  
RBP is reported to be a nutritional marker with shortest half-life (0.5 days) among RTPs 
in humans (Winkler et al., 1989a). Contrary to our expectations, plasma RBP concentration 
showed no significant change during caloric restriction period in this study. Although RBP is 
related to the vitamin A transport both in dog and human, the difference in vitamin A 
metabolism was reported in dogs. Unlike in humans, precursor of vitamin A is transported 
from liver to the target organs mainly as retinol esters forming complex with lipoproteins 
(LDL and VLDL) in dogs instead of retinol - RBP complex (Schweigert et al., 1990). The 
low importance of RBP in canine vitamin A metabolism might be the reason for the negative 
result in this study.  
Dogs with elevated CRP level, iron deficiency anemia, or liver cirrhosis were excluded in 
this study. Tf is one of the negative acute phase reaction substances, which decreases along 
with infection or inflammation. Invert correlations between plasma Tf and acute phase 
proteins such as C-reactive protein (CRP) concentration have been reported in several 
studies (Fleck, 1989). Liver cirrhosis and iron deficiency anemia are also reported to 
influence the value of plasma Tf concentrations in human medicine (Kalantar-Zadeh et al., 
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1998). Although Tf would be a novel nutritional marker in dogs, these factors should be 
taken into consideration when assessing the plasma Tf concentration value correctly.  
The greatest limitation in this study was the lack of gold standard for the short-term 
nutritional status in dogs. As body weight and BCS did not change during the restriction 
period, the relevance of the food restriction protocol is not clear in the calorie restriction 
study. Furthermore, the amounts of calorie intake in anorexic dogs were estimated according 
to the interview with the owners. Further study is needed to examine the relation between 
plasma Tf concentrations and nutritional state by using more accurate data on daily calorie 
intake. As nutritional status was affected not only by the amount of calorie intake but also 
intestinal absorption, functional analysis for nutritional absorption should be performed and 
compared with plasma Tf concentration.  
In conclusion, the present study showed that plasma Tf concentration would be useful as a 
dynamic nutritional assessment marker in dogs. By using plasma Tf concentration in 
conjunction with the conventional static marker such as albumin, body weight change and 
BCS, it might be possible to evaluate the objective nutritional state in dogs with malnutriton.  
 25 
 Table 1.  Patient population characteristics in the study 
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Fig. 1. Time-course change of mean value of plasma Tf concentration (filled circle), 
plasma RBP concentration (open circle) and albumin concentration (open square) of 5 
healthy dogs receiving caloric restriction test according to test 1 protocol described in the 
Materials and Methods are indicated. An error bar denotes SD value. The amount of food 
intake was increased for 7 days (day 0 – 7), decreased for 14 days (day 7 – 21, indicated as 
shadow area) and re-increased for 14 days (day 21 – 35). Asterisks denote the time points 
with significant difference when compared to day 7 (P< 0.05). 
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Fig. 2.  Plasma Tf concentration (A) and plasma albumin concentration (B) of the dogs 
with chronic gastrointestinal disease are indicated. Dogs were divided to the ≥50% RER 
group and the <50% RER group based on the estimated daily calorie intake. A horizontal bar 
indicates the average value of each group and the shadow area indicates the reference range. 
Asterisk indicate statistical significance (P< 0.05). 
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Chapter 2 
 
Plasma transferrin concentration as a nutritional marker 
in malnourished dogs with nutritional treatment 
  
 29 
Abstract  
 
Rapid turnover proteins such as transferrin (Tf) are used as dynamic nutritional 
assessment proteins in human medicine. However, nutritional status in veterinary medicine 
is mostly assessed on the basis of classical static factors such as body weight, body 
condition score and plasma albumin level. This study evaluated the clinical usefulness of Tf 
as nutritional assessment marker by measuring plasma Tf concentrations in malnourished 
dogs before and after nutritional treatment. Post plasma Tf concentrations were significantly 
higher than those of pre treatment, although albumin concentration did not change 
significantly. Numbers of dogs that exhibited increases in plasma Tf concentrations are 
significantly related to weight gain. Furthermore, the survival rates at day 60 after the 
treatment initiation were significantly higher in dogs with plasma Tf concentrations above 
the reference value (180 mg/dL) after the nutritional treatment than those with a plasma Tf 
concentration <180 mg/dL. In conclusion, the serial measurement of plasma Tf 
concentration is related to nutritional condition and would be a candidate for novel 
nutritional assessment marker in dogs. 
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Introduction 
 
Malnutrition negatively affects the recovery process in various diseases. Compromised 
immune function and delayed wound healing are reported in humans with malnutrition 
(Bistrian et al., 1975; Haider and Haider, 1984; Roubenoff and Kehayias, 1991; Seltzer et al., 
1979; Steffee, 1980; Thibault and Pichard, 2010; Young, 1988). Effective nutritional therapy 
improves mortality in malnourished surgical patients or seriously ill patients (Heyland, 
2000; Kuvshinoff et al., 1993; Mullen et al., 1980; Smale et al., 1981). Nutritional 
assessment should be the first step to provide appropriate nutritional treatment (Oka et al., 
2006). 
In dogs, malnutrition during hospitalization is reported to impair clinical signs and 
prognosis (Chan, 2004; Remillard et al., 2001). The nutritional status of diseased dogs is 
currently estimated on the basis of body weight change (Armstrong and Lippert, 1988; 
Michel, 1993; Michel et al., 2004), body condition score (BCS) (Michel, 1993; Michel et al., 
2004), and several serum biochemical values (Michel, 1993). Body weight change is the 
most reliable factor for assessing nutritional status. However, it is a static factor and does not 
reflect short-term changes. In addition, fluid accumulation in the third space directly affects 
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body weight, making assessment difficult. Although BCS is a convenient and non-invasive 
method for estimating the nutritional status of dogs, it is a subjective marker and is 
influenced by body size and shape among different breeds. Plasma albumin concentration is 
a biochemical parameter commonly used to assess nutritional status in dogs (Michel, 1993). 
As the half-life of albumin is 20 days in humans (Winkler et al., 1989a) and 8.2 days in dogs 
(Dixon et al., 1953), it is expected to be a short- to medium-term nutritional assessment 
marker. However, plasma albumin concentration is readily influenced by fluid accumulation, 
hepatic function, and protein loss from the gut and kidneys. In addition, plasma albumin 
concentration rarely decreases unless malnutrition is in the advanced stage, possibly in part 
because of the large capacity of the liver to synthesize albumin (Shetty et al., 1979). 
Tf is mainly synthesized in the liver and plays an important role in iron transport 
(Kalantar-Zadeh et al., 1998). Decreased intestinal protein uptake promptly reduces Tf 
production, which directly depletes plasma Tf concentration (de Jong et al., 1988; Hassanein 
el et al., 1998). I previously reported that plasma Tf concentrations are decreased in 
experimentally induced undernourished dogs, suggesting that Tf may be a dynamic 
nutritional marker in dogs. Therefore, this study evaluated the relationships between plasma 
Tf concentration and the nutritional condition and prognosis in diseased dogs receiving 
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nutritional treatment. 
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Materials and methods  
 
Dogs and nutritional therapies 
Thirty-three dogs referred to the Veterinary Medical Center of the University of Tokyo 
with clinical signs of anorexia (i.e., taking <50% resting energy requirement [RER] per day 
over 3 days) were included in this study. Caloric intake was estimated on the basis of 
interviews with the dogs’ owners before nutritional treatment. RER was calculated by the 
following formula: RER = 70 × (body weight in kg)
0.75 
(Chan, 2004). All dogs received 
nutritional treatments which meet the RER of each patient through oral-assisted feeding 
(OF), enteral-assisted feeding (EF) including esophagostomy, gastrostomy or jejunostomy 
tube feeding, or parenteral-assisted feeding (PF). The OF and EF dogs except jejunostomy 
tube feeding were fed mainly semi-digestion liquid diet (CliniCare, Abbott Laboratories) or 
high density diet (a/d, Hill’s Pet Nutrition). For jejunostomy tube feeding, highly digested 
nutrition agent (Convalescence Support, Royal Canin) was used. The PF dogs received 
continuous intravenous fluids prepared by mixing dextrose, lipid, and amino acid products 
to meet RER of each patient. Body weight, BCS, and plasma Tf and albumin concentrations 
were monitored in all dogs at before and after the nutritional treatment. Dogs with 
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incomplete medical records or liver failure were excluded from this study.  
 
Subject characteristics 
  For the purpose of evaluating the relationships between plasma Tf concentration and the 
effect of nutritional treatment, dogs with pleural effusion and ascites were excluded in order 
to accurately measure body weight changes. Twenty-one dogs of 33 anorexic dogs were 
included for this purpose; 9 female (3 intact), and 12 male (6 intact). The median age was 
113 months (range: 7–173 months), and median BCS was 2/5 (range: 1–3). The primary 
disease causing malnutrition was chronic inflammatory gastrointestinal disease in 6 dogs; 
pancreatitis in 3 dogs; pyloric stenosis in 2 dogs and lymphangiosarcoma, gastric 
adenocarcinoma, gastric delayed emptying, oral melanoma, and holoprosencephaly, 
gastrointestinal lymphoma, esophageal diverticulum, megaesophagus, myelodysplastic 
syndrome, and encephalomyelitis in 1 dog each, respectively. Nutritional treatments 
performed include OF only (n=11), EF (n=5), PF (n=1), and both EF and PF (n=4).  
   For the purpose of evaluating the association between Tf and prognosis, neoplastic 
diseases were excluded and the disease was restricted to the chronic inflammatory 
gastrointestinal diseases. Twenty dogs histopathologically diagnosed as chronic 
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inflammatory gastrointestinal diseases were recruited. Nine dogs were female (2 intact), and 
11 were male (10 intact). The median age was 105.5 months (range: 58–174 months), and 
the median BCS was 2/5 (range: 1–3). Fifteen dogs were diagnosed as chronic enteritis, 3 as 
chronic gastritis accompanying pyloric stenosis, and 1 each as chronic colitis and functional 
ileus. Six of 20 dogs had apparent ascites due to the hypoalbuminemia as a result of 
protein-losing enteropathy (PLE). Nutritional treatments included OF only (n=9), EF (n=3), 
PF (n=6) and, both EF and PF (n=2). 
   For the purpose of evaluating the serial change of plasma Tf concentrations, one dog 
with gastrointestinal lymphoma receiving continuous nutritional support (both OF and EF) 
was monitored. Plasma samples for measurement of Tf and albumin concentration were 
collected on day 0 (pre treatment), 21, 28, 35, 41, 42 at early morning under fasting 
condition. Body weight and body condition score were also monitored during the study. 
 
Measurement of plasma Tf and albumin concentrations 
Fasting plasma was separated from heparinized blood and immediately stored at −20°C. 
Plasma Tf concentrations was determined using a commercial kit (Canine Tf ELISA kit: 
GenWay Biotech, San Diego, CA, USA) according to the manufacturer’s protocol; all 
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samples were measured in duplicate. Plasma albumin concentrations were measured using a 
biochemical analyzer (Dry-chem 7000V: Fujifilm Co., Tokyo, Japan). Plasma Tf and 
albumin concentrations were measured at the onset of nutritional treatment (pre-treatment) 
and after treatment (post-treatment). The interval between both time points ranged from 
8–30 days. The reference value for plasma Tf concentration was 180 mg/dL according to the 
lower limit of the reference range (i.e., mean − 2SD) of healthy dogs as shown in chapter 1. 
The reference value for plasma albumin concentration was 2.6 g/dL according to the lower 
limit of our reference range. The survival rates on days 60 after the initial treatment were 
assessed in each group. 
 
Statistical analysis  
Statistical analyses were performed using JMP version 9 (SAS Institute, Cary, NC, 
USA). The Wilcoxon Signed – Ranks Test was used to compare plasma Tf and albumin 
concentrations between pre- and post treatment. The Fisher’s exact test was used to compare 
the proportion of dogs categorized by plasma Tf and albumin concentrations and body 
weight change. The differences of 60-day survival rates after the initiation of nutritional 
treatment were analyzed using the log-rank test. The level of statistical significance was set 
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at P < 0.05. 
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Results 
 
Changes in plasma Tf and albumin concentrations before and after nutritional treatment 
Plasma Tf and albumin concentrations were compared before and after nutritional 
treatment. The median plasma Tf concentrations before and after treatment were 150 mg/dL 
(range: 71–320 mg/dL) and 190 mg/dL (range: 39 – 390 mg/dL), respectively. The median 
plasma albumin concentrations before and after treatment were 2.8 g/dL (range: 2.1–3.9 
g/dL) and 3 g/dL (range: 1.6 – 3.9 g/dL). Plasma Tf concentrations were significantly higher 
at post-treatment than pre-treatment (P<0.05) (Fig.1A). In contrast, plasma albumin 
concentrations did not differ between pre- and post-treatment (P=0.5766) (Fig.1B).  
The changes in plasma Tf and albumin concentrations and body weight in each case 
were subsequently analyzed. Among 15 dogs with increased plasma Tf concentration, 10 
dogs showed increases in body weight. In contrast, only 1 of 6 dogs with decreased or 
unchanged plasma Tf concentration showed increases in body weight. The proportion of 
dogs that exhibited increases in plasma Tf concentrations was significantly related to weight 
gain (P<0.05) (Table.1). Meanwhile, the numbers of dogs that increased in plasma albumin 
concentrations were not significantly related to weight gain (P=0.4663). 
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   Next, the number of dogs with plasma Tf concentrations above the reference range (i.e., 
≥180 mg/dL) were examined. Nine of 11 dogs with increased body weight, 5 of 10 dogs 
without increase of body weight had ≥180mg/dL plasma Tf concentrations after treatment, 
respectively. The number of dogs with plasma Tf concentrations ≥180 mg/dL was not 
significantly related to body weight gain (P=0.1223).  
 
Survival rates 60 days after nutritional treatment initiation  
The dogs were divided into 2 groups according to Tf and albumin concentrations: 
plasma Tf concentrations before or after treatment ≥180 and <180 mg/dL, and plasma 
albumin concentrations before or after treatment ≥2.6 and <2.6 g/dL. The survival rates 60 
days after the initiation of treatment in each group are summarized in Table 2. There was a 
significant difference in the survival rates 60 days post-treatment between dogs with 
post-treatment plasma Tf concentrations ≥180 and <180 mg/dL (P < 0.05). The survival 
rates 60 days post-treatment were also significantly different between dogs with 
pre-treatment plasma albumin concentrations ≥2.6 and <2.6 g/dL (P < 0.05). 
 
Serial measurement of plasma Tf and albumin concentrations in a dog under nutritional 
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treatment (Fig. 2) 
  One beagle dog diagnosed as gastrointestinal lymphoma showed anorexia lasting for 
several days. Body weight was 8.6 kg and BCS was 2 at day 0. Nutritional support (OF) was 
started from day 0, when plasma Tf concentration was 210 mg/dL. Plasma Tf concentrations 
increased to 250 mg/dL and 260 mg/dL on day 21 and 28, respectively. Since the OF 
became difficult, percutaneous endoscopic gastrostomy (PEG) tube was installed on day 33. 
Endoscope examination and biopsy of the duodenum was performed concurrently. 
Histopathological evaluation of the endoscopic biopsy specimen revealed villous atrophy, 
crypt disappearance and inflammatory cell infiltration in intestinal mucosa together with 
lymphoma. Although caloric intake by EF had met the RER throughout the observation 
period, plasma Tf concentration decreased gradually to 170 mg/dL on day 42, which was 
below the reference value of healthy dog. The dog died on day 42. On the other hand, 
plasma albumin concentration (mean 2.6 g/dL, range; 2.4-2.8 kg) (Fig. 2), body weight 
(mean 8.8kg, range; 8.6-9.4kg) and BCS (mean 2/5, range; 2-2) were not changed 
throughout the nutritional treatment. 
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Discussion 
 
I previously reported plasma Tf concentrations decrease in both anorexic dogs with 
various diseases and experimentally induced undernourished dogs. The present results show 
that plasma Tf concentrations changed depending on nutritional state after nutritional 
treatment. Furthermore, the results suggest that Tf concentrations after nutritional treatment 
would be indicative of the prognosis of malnourished dogs with gastrointestinal diseases. 
Plasma Tf concentrations increased significantly in malnourished dogs when nutritional 
treatment was successful, approaching weight gain in many cases. Although the rate of 
change varied among cases, the variation of plasma Tf concentrations during nutritional 
treatment could be a useful marker in dogs as shown in chapter 1. In contrast, plasma 
albumin concentrations did not change significantly between pre- and post-treatment. This is 
considered to be due to the relatively large body pool of albumin in dogs. Therefore, 
nutritional condition is not reflected by increased plasma albumin concentration.  
The survival rate at day 60 after nutritional treatment was significantly higher in dogs 
with plasma Tf concentration ≥180 mg/dL. Therefore, the plasma Tf concentration level 
after nutritional treatment is a candidate prognostic factor for malnourished dogs. In human 
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medicine, patients with higher serum Tf concentrations have longer survival times than 
those with lower Tf concentrations (Inoue et al., 1995; Reeds and Laditan, 1976). The 
present results are concordant with these human studies. Another study showed that an 
increase in plasma Tf concentration within 4–7 days after the initiation of treatment is 
associated with better prognosis (Reddy et al., 1970). As the interval between the 2 
measurement points (i.e., before and after treatment) varied among cases (range: 12–29 
days) in this study, it is necessary to evaluate the appropriate monitoring time of plasma Tf 
concentrations during nutritional treatment. The reference values used in the present study, 
180 mg/dL, was defined on the basis of the data of healthy dogs in my previous study. 
According to the present data, this reference value may be appropriate when using plasma 
Tf concentration as a clinical marker of nutritional condition. 
Lower plasma albumin concentrations before treatment also influenced the survival 
rates. Considering that 6 dogs with low plasma albumin concentrations at the onset of 
treatment were diagnosed with PLE and that hypoalbuminemia is reported to be a prognostic 
factor of canine chronic enteropathy (Allenspach et al., 2007), the significance of the 
association between survival rate and albumin concentration before treatment is indicative 
of the severity of PLE itself. As rapid turnover proteins such as Tf are preserved their blood 
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levels even in human patients with PLE (Takeda et al., 2003), Tf could be especially useful 
to assess the nutritional conditions in dogs with PLE. 
   Plasma Tf concentration was serially monitored in a dog with gastrointestinal lymphoma. 
Although the calorie intake had met the RER by nutritional treatment, plasma Tf 
concentration continued to decrease during a week before death. The histopathological 
evaluation indicated the villous atrophy and crypt disappearance of the intestinal mucosa. In 
this case, the ability of intestinal mucosa to absorb nutrient might be significantly decreased. 
It would be important to consider intestinal absorption ability of the dog when deciding the 
protocol of nutritional support (i.e., OF, EF or PF). Therefore, intestinal integrity and 
function, as well as nutritional marker such as Tf should be assessed before the initiation of 
enteral-assisted feeding in critically ill dogs. 
   This study has several limitations that should be addressed. First, various diseases 
including malignant tumors were included to evaluate the association between plasma Tf 
concentrations before and after the nutritional treatment. The type of disease and its severity 
could affect plasma Tf concentrations. Tf is reported to decrease with infection or 
inflammation; moreover, plasma Tf and C-reactive protein (CRP) concentrations are 
reported to be negatively correlated (Fleck, 1989; Krzystek-Korpacka et al., 2008). However, 
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CRP was not measured in many dogs in the present study. Second, several nutritional 
therapies including force feeding, enteral and parenteral feeding, and surgery were 
administered in this study. For example, parenteral intravenous feeding may affect Tf 
concentrations by altering protein synthesis in the liver. Therefore, additional studies using 
greater numbers of dogs with a single disease and the same nutritional treatment are 
required.  
In conclusion, to the best of our knowledge, this is the first study demonstrating the 
clinical usefulness of plasma Tf concentration as a nutrition assessment marker in dogs. 
Monitoring plasma Tf concentration together with the conventional static markers albumin, 
body weight, and BCS could be useful for evaluating nutritional status and prognosis during 
nutritional treatment in dogs. 
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Table 1. Plasma Transferrin and albumin concentration and body weight change in dog 
with various primary diseases dogs without pleural effusion and ascites 
 
  Body weight  
      Increased 
a) 
   (n=11)
 
Not change or decreased 
b)
 
(n=10) 
P value 
Transferrin 
Increased (n=15) 10 5 
0.0382 
Not change or decreased (n=6) 1 5 
Albumin 
Increased (n=8) 5 3 
0.4663 
Not change or decreased (n=13) 6 7 
Statistically significant by Fisher’s exact test 
a) Number of dogs with increased body weight after the nutritional therapy. 
b) Number of dogs with decreased or unchanged body weight after the nutritional therapy. 
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Table 2. Plasma transferrin and albumin concentrations and survival rate on day 60 after 
the nutritional treatment in dogs histopathologically diagnosed as chronic inflammatory 
gastrointestinal diseases 
 
Evaluation criteria  Survival rate (%) P value 
Pre-treatment 
Transferrin (mg/dL) 
≥ 180 (n=5) 60 
0.4655 
< 180 (n=15) 40 
Albumin (g/dL) 
≥ 2.6 (n=9) 78 
0.0234 
< 2.6 (n=11) 18 
Post-treatment 
Transferrin (mg/dL) 
≥ 180 (n=9) 78 
0.0147 
< 180 (n=11) 18 
Albumin (g/dL) 
≥ 2.6 (n=7) 71 
0.1176 
< 2.6 (n=13) 31 
Statistically significant by Log-rank test 
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Fig. 1. Plasma transferrin (Tf) (A) and albumin (B) concentrations before and after 
nutritional treatment. Data are presented as the medican with the 25
th
-75
th
 percentile range in 
each box plot. Whiskers indicate the highest and lowest data points. Dotted lines show the 
lower limit of the reference ranges of plasma (A) Tf (i.e., 180 mg/dL) and (B) albumin (i.e., 
2.6 g/dL) concentrations. Pre: pre-treatment, Post: post-treatment, Tf: transferrin. Significant 
difference was observed between pre- and post-Tf concentration (P < 0.05), but was not 
between pre- and post- albumin concentrations (P = 0.5766). The Wilcoxon Signed - Ranks 
Test was used to compare plasma Tf and albumin concentrations between pre- and post 
treatment. 
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Fig. 2. Serial measurement of plasma transferrin (Tf) (●) and albumin concentration (○) in 
a dog under nutritional treatment. Caloric intake was estimated on the basis of resting energy 
requirement (RER).  
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Chapter 3 
 
 50 
 
Chapter3 p.49-72 
Serum diamine oxidase activity in dogs with chronic 
enteritis 
本章の内容は The Journal of Veterinary Medical Science 
に 5年以内に投稿する計画があるため公表できません。 
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            Conclusion 
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   Nutritional assessment is the most important first step for planning nutritional treatments. 
However, nutritional status of diseased dogs is currently estimated on the basis of body 
weight a body condition score (BCS), and does not reflect short-term nutritional changes. I 
hypothesized that rapid turnover proteins (RTPs) including tranferrin (Tf) could also be 
useful in dogs as a dynamic nutritional marker as well as in human. 
   In Chapter 1, the total calorie intake was restricted to <50% resting energy requirement 
(RER) in healthy dogs for 2 weeks. Plasma Tf concentrations were significantly decreased, 
which was gradually recovered after increasing the caloric intake back to adequate level. 
Furthermore, plasma Tf concentrations were significantly decreased in severely anorexic 
dogs (<50% RER) compared to non-severely anorexic dogs (≥50% RER group). In Chapter 
2, plasma Tf concentrations were measured in malnourished dogs before and after the 
nutritional treatment. Plasma Tf concentrations were significantly higher after the treatment 
compared to those before treatment. Numbers of dogs that exhibited increases in plasma Tf 
concentrations are significantly related to weight gain. The survival rates at day 60 after the 
treatment initiation were also significantly higher in dogs with plasma Tf concentrations 
above the reference value (180 mg/dL) after the nutritional treatment than those with a 
plasma Tf concentration <180 mg/dL. Taken together with the results in Chapters 1 and 2, 
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plasma Tf concentration would be a useful marker to assess short-term nutritional change in 
malnourished dogs, especially with nutritional treatment. 
   Muscle loss, also expressed as decline in lean body mass (LBM), adversely affects 
immune function and wound healing and is independently associated with mortality in 
humans (Anker et al., 1997; Freeman and Roubenoff, 1994). Decrease in LBM is usually 
followed by the decreased rate of protein synthesize in liver, which is possibly reflected as 
decrease of plasma Tf concentration. To assess the degree of LBM decline or decrease in 
protein synthesis, measurement of plasma Tf concentration may be useful as an objective 
marker in dogs. Additional research is needed to investigate the relation between plasma Tf 
concentration and LBM evaluated by using other methods. In the field of veterinary 
medicine, muscle condition score (MCS) was developed and recommended for assessing 
muscle mass (Michel et al., 2011). Scoring MCS is dependent on visual examination and 
palpation over the temporal bones, scapulae, lumbar vertebrae and pelvic bones. Therefore, 
MCS is quite subjective and not to be widely used in clinical practice. In human medicine, 
computer tomography, dual-energy x-ray absorptiometry or deuterium oxide (D2O) dilution 
method (Son et al., 1998) have been used to estimate LBM. As a clinical marker, 
measurement of plasma Tf concentration would be more convenient compared with those 
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parameters which need specialized equipment or anesthesia. In addition, serial and repetitive 
assessment would become possible by measurement of plasma Tf concentration, which 
would be helpful especially for planning of appropriate nutritional treatment in hospitalized 
patients. 
   Tf is considered to be the RTP with third shortest half-life after Transthyretin (TTR) and 
RBP in human. Although RBP was not suitable as a nutritional marker in dogs in this study, 
other RTPs such as human growth hormone (hGH), insulin-like growth factor 1 (IGF-1) or 
IGFBP-3 would be alternative candidates metabolizing more rapidly than Tf (Baxter et al., 
1998; Gianotti et al., 2002). Recently in human medicine, nutritional assessment markers 
such as TTR and albumin are also used with inflammatory markers including CRP, serum 
amyloid A (SAA) and α-1 acid glycoprotein to evaluate patient's overall status. Several 
indices such as Prognostic Inflammatory and Nutritional Index (PINI), Glasgow Prognostic 
Score (GPS) have been developed and reported to be useful to know the prognosis of each 
patient (da Silva et al., 2013; Ingenbleek and Carpentier, 1985; Vehe et al., 1991). Although 
these approaches have not been applied in dogs yet, simultaneous evaluation of both plasma 
Tf concentrations and CRP would be also useful to monitor the overall status in 
malnourished dogs. 
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   Serial measurement of plasma Tf concentration in a dog with gastrointestinal lymphoma 
in Chapter 2 revealed that plasma Tf continued to decrease during a week before death even 
though the calorie intake had met the RER. Therefore, intestinal integrity and function, as 
well as nutritional marker should be assessed before the initiation of enteral-assisted feeding 
in critically ill dogs. At present, the intestinal integrity is estimated based on 
histopathological evaluation using the endoscopic biopsy sample. However, it is not suitable 
for repetitive evaluation, especially in critically ill dogs due to the need of anesthesia. In 
Chapter 3, I evaluated serum and duodenal DAO activity in dogs with chronic enteritis. 
DAO activity was found to be especially high in duodenum and there was significant 
correlation between serum and duodenal DAO activities. Serum DAO activities in dogs with 
chronic enteritis were significantly decreased compared to those in healthy dogs and the 
width of mucosal villus showed tendency of correlation with serum DAO activity.  
   In order to assess the usefulness of serum DAO activity as a clinical marker of mucosal 
integrity, it is necessary to investigate its relevance with intestinal permeability and 
absorption ability by using sugar absorption test (Allenspach et al., 2006) and measurement 
of plasma citrulline concentration (Windmueller and Spaeth, 1981). It might be also 
informative to examine serum DAO activity after vincristine administration, which is known 
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to have gastrointestinal side effects to dogs (Withrow and David, 2007).  
   Enteral nutrition (EN) has advantage to maintain intestinal integrity (Mohr et al., 2003) 
and immunological integrity (Alverdy et al., 1985; Alverdy et al., 1992; Tanaka et al., 1991) 
and cause bacterial translocation (BT) at lower rate compared to parenteral nutrition (PN) by 
preventing mucosal atrophy (Gianotti et al., 1994). In contrast, it has been reported that 
patients of Crohn's disease and patients receiving total PN showed lower plasma DAO 
activity compared to healthy humans and patients receiving EN. The report also showed that 
low serum DAO activity seems to reflect atrophy of intestinal mucosa. These previous 
findings indicate that measuring serum DAO activity is important to estimate mucosal 
integrity and to determine a adequate nutritional treatment. Although further study is needed, 
serum DAO activity might be related to and could be a marker for the status of mucosal 
villus integrity in dog as well as in human. 
   Even in a recent study, the proportion of hospitalized canine patients in negative-energy 
balance is reported to exceed 70%. One of the reasons for the insufficient nutritional support 
is the lack of convenient assessment marker for malnourished dogs. In the series of my 
thesis studies, I evaluated the usefulness of two laboratory markers; Tf as a nutritional 
marker and DAO as an intestinal integrity marker. Although these parameters cannot be 
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applied to veterinary medicine instantly, I hope the results obtained in this study will 
contribute to the adequate nutritional support for critically ill dogs in the future. 
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